Rückruf der Charge BIC0053 bis auf Stufe Detailhandel
Publication of the "Good practice for the reprocessing of medical devices for Swiss health facilities" (GPA), version 2022
11,467 reports of suspected adverse vaccination reactions evaluated
Rückruf der Charge 21386 bis auf Stufe Detailhandel
Corona medication Xevudy from GlaxoSmithKline (containing the active substance sotrovimab) granted temporary authorisation in Switzerland
Corona medication Regkirona from iQone Healthcare Switzerland (containing the active substance regdanvimab) granted temporary authorisation in Switzerland
Swissmedic Journal Dezember 2021
Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3
Information on the new coronavirus (SARS-CoV-2)
Vaccines against COVID-19
20 years Swissmedic
Contact for members of the public
Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance.
Just send an e-mail to firstname.lastname@example.org or use our contact form. Thank you.
Communications regarding the safety of medicines
Product groups, services
Stay up to date
Our news subscription service provides on-going information via e-mail.
Reporting undesirable effects and incidents
Information concerning the new EU-Regulations as well as their implementation in Switzerland.
The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.
Swissmedic, Swiss Agency for Therapeutic Products
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
For further information...